hyperdemocracy/usc-billstatus huggingface dataset:
To authorize the Secretary of the Interior to acquire certain property related to the Fort Scott National Historic Site in Fort Scott, Kansas.

Bill: 114-hr-2333
Sponsor: Rep. Jenkins, Lynn [R-KS-2]
Introduced: 2015-05-14 in the House
Policy area: Public Lands and Natural Resources
Subjects: Historic sites and heritage areas
Kansas
Land transfers

Summary:
action_date: 2015-05-14
text: 
This bill authorizes the Department of the Interior to acquire the structure known as &quot;Lunette Blair,&quot; which is related to the Fort Scott National Historic Site in Fort Scott, Bourbon County, Kansas.

action_date: 2016-11-14
text: 
(Sec. 1) This bill authorizes the Department of the Interior to acquire the structure known as &quot;Lunette Blair,&quot; which is related to the Fort Scott National Historic Site in Fort Scott, Bourbon County, Kansas. 
 
The boundary of the Fort Scott National Historic Site in Kansas is modified as depicted on the map referred to as &quot;Fort Scott National Historic Site Proposed Boundary Modification,&quot; and dated February 2016. 
Interior may acquire by donation or exchange only lands and interests in land within the boundaries of the site. 
Interior may not acquire any such lands or interests in land by condemnation. 
No private property or nonfederal property shall be included within the site without the written consent of the owner of that property. 
Nothing in this bill, the establishment of the site, nor the management plan for the site, shall be construed as creating a buffer zone outside of the site.

Legislative actions:
action_date: 2016-11-14
text: Placed on the Union Calendar, Calendar No. 643.
action_date: 2016-11-14
text: Reported (Amended) by the Committee on Natural Resources. H. Rept. 114-820.
action_date: 2016-11-14
text: Reported (Amended) by the Committee on Natural Resources. H. Rept. 114-820.
action_date: 2016-07-13
text: Ordered to be Reported (Amended) by the Yeas and Nays: 22 - 14.
action_date: 2016-07-13
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-07-12
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-07-12
text: Subcommittee on Federal Lands Discharged.
action_date: 2016-06-23
text: Subcommittee Hearings Held.
action_date: 2015-06-04
text: Referred to the Subcommittee on Federal Lands.
action_date: 2015-05-14
text: Referred to the House Committee on Natural Resources.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
Refundable Child Tax Credit Eligibility Verification Reform Act of 2015

Bill: 114-hr-2334
Sponsor: Rep. Johnson, Sam [R-TX-3]
Introduced: 2015-05-14 in the House
Policy area: Taxation
Subjects: Income tax credits
Tax administration and collection, taxpayers
Tax treatment of families

Summary:
action_date: 2015-05-14
text: 

Refundable Child Tax Credit Eligibility Verification Reform Act of 2015 

 
 Amends the Internal Revenue Code, with respect to the child tax credit, to require taxpayers claiming such credit to provide their social security numbers on their tax returns. 
 
Prohibits taxpayers who improperly claimed such credit in a previous year from claiming such credit during a disallowance period of: (1) 2 years for claims made with reckless or intentional disregard of rules governing such credit, or (2) 10 years for fraudulent claims.
 
Requires the Department of the Treasury to prescribe a form for completion by paid income tax preparers in connection with claims for the refundable portion of the child tax credit. Imposes a penalty on preparers who fail to comply with due diligence requirements for claiming the refundable portion of the credit. 


Legislative actions:
action_date: 2015-05-14
text: Referred to the House Committee on Ways and Means.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
Stop Tampering of Prescription Pills Act of 2015

Bill: 114-hr-2335
Sponsor: Rep. Keating, William R. [D-MA-9]
Introduced: 2015-05-14 in the House
Policy area: Health
Subjects: Administrative law and regulatory procedures
Administrative remedies
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Prescription drugs

Summary:
action_date: 2015-05-14
text: 

Stop Tampering of Prescription Pills Act of 2015

 
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to deny approval to a new oral opioid (a drug with effects similar to opium, such as morphine) that does not have properties that make the drug significantly more difficult to abuse if an abuse-deterrent drug containing the same opioid is available. The FDA may approve an opioid drug that is not abuse-deterrent if approval is necessary to prevent or alleviate a drug shortage or to address a significant unmet public health need.
 
To be approved by the FDA, a generic version of an abuse-deterrent brand name drug must be at least comparably abuse-deterrent and its active components must not differ in any material respect from the brand name drug.
 
An approved generic drug is not bioequivalent to, and does not have the same therapeutic effect as, a brand name drug that becomes abuse-deterrent unless the generic drug is at least comparably abuse-deterrent.
 
Approval of a generic oral opioid is withdrawn if the brand name drug is not abuse-deterrent and not available and there is an approved abuse-deterrent drug available that contains the same opioid in the same dose.
 Approval of an oral opioid is withdrawn if the drug is not abuse-deterrent and there is an approved abuse-deterrent drug available that contains the same opioid. Withdrawal of approval may be waived by the FDA for a drug intended for a special needs population. The FDA must delay withdrawal to give the drug sponsor an opportunity to obtain approval for an abuse-deterrent formulation of the drug.

Legislative actions:
action_date: 2015-05-15
text: Referred to the Subcommittee on Health.
action_date: 2015-05-14
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
Sunshine in Litigation Act of 2015

Bill: 114-hr-2336
Sponsor: Rep. Nadler, Jerrold [D-NY-10]
Introduced: 2015-05-14 in the House
Policy area: Law
Subjects: Civil actions and liability
Evidence and witnesses
Freedom of information
Government information and archives
Health information and medical records
Right of privacy

Summary:
action_date: 2015-05-14
text: 

Sunshine in Litigation Act of 2015

 
Amends the federal judicial code to prohibit a court, in any civil action in which the pleadings state facts relevant to the protection of public health or safety, from entering an order restricting the disclosure of information obtained through discovery, approving a settlement agreement that would restrict such disclosure, or restricting access to court records, unless in connection with such order the court has first made independent findings of fact that: (1) the order would not restrict the disclosure of information relevant to the protection of public health or safety; or (2) the public interest in the disclosure of past, present, or potential health or safety hazards is outweighed by a specific and substantial interest in maintaining the confidentiality of the information, and the requested protective order is no broader than necessary to protect the confidentiality interest asserted.
 
Prohibits a court from: (1) enforcing any provision of an agreement between or among parties to the civil action, or an order entered under this Act, that restricts a party from disclosing information to any federal or state agency with authority to enforce laws regulating an activity relating to such information; or (2) enforcing any provision of a settlement agreement between or among parties to such civil action that prohibits a party from disclosing that a settlement was reached or the terms of the settlement (excluding any money paid) that involve matters relevant to the protection of public health or safety, or from discussing matters relevant to the protection of public health or safety involved in such civil action. Excepts from this enforcement prohibition (thus allowing enforcement of) a settlement agreement provision about which the court finds that the public interest in the disclosure of past, present, or potential public health or safety hazards is outweighed by a specific and substantial interest in maintaining the confidentiality of the information in question, and the requested protective order is no broader than necessary to protect the confidentiality interest asserted.
 
Creates a rebuttable presumption that the interest in protecting personally identifiable information of an individual outweighs the public interest in disclosure.
 
Declares that nothing in this Act shall be construed to permit, require, or authorize the disclosure of classified information, as defined under the Classified Information Procedures Act.


Legislative actions:
action_date: 2015-06-26
text: Referred to the Subcommittee on the Constitution and Civil Justice.
action_date: 2015-05-14
text: Referred to the House Committee on the Judiciary.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices.

Bill: 114-hr-2337
Sponsor: Rep. Pitts, Joseph R. [R-PA-16]
Introduced: 2015-05-14 in the House
Policy area: Health
Subjects: Drug safety, medical device, and laboratory regulation
Health technology, devices, supplies
Manufacturing

Summary:
action_date: 2015-05-14
text: 
This bill amends the Federal Food, Drug, and Cosmetic Act to replace the requirement that the Food and Drug Administration (FDA) prioritize review of breakthrough medical devices with a requirement that the FDA establish a program to provide priority review for breakthrough medical devices.
 
Prior to submitting an application for approval, a medical device sponsor may request that the FDA designate the medical device for priority review. The FDA must provide a summary of the basis for its determination regarding designation.
 
To expedite the development and review of designated medical devices, the FDA must:
 
 
assign a team of staff for each device,
 
adopt an efficient process for dispute resolution,
 
provide for interactive communication with the device sponsor,
 
expedite review of manufacturing and quality systems compliance,
 
disclose to the sponsor in advance the topics of any consultation between the FDA and external experts or an advisory committee and provide the sponsor the opportunity to recommend external experts,
 
assign staff to address questions by institutional review committees concerning investigational use of the device.
 
 The FDA may: (1) coordinate with the sponsor regarding early agreement on a data development plan; (2) take steps to ensure that the design of clinical trials is as efficient as practicable; (3) utilize timely postmarket data collection; and (4) agree to clinical protocols, subject to an FDA determination that changes are required to prevent an unreasonable risk to the public health or that a substantial scientific issue is essential to the safety or effectiveness of the device.

Legislative actions:
action_date: 2015-05-15
text: Referred to the Subcommittee on Health.
action_date: 2015-05-14
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.

Bill: 114-hr-2338
Sponsor: Rep. Pitts, Joseph R. [R-PA-16]
Introduced: 2015-05-14 in the House
Policy area: Health
Subjects: Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health information and medical records
Medical research
Research administration and funding

Summary:
action_date: 2015-05-14
text: 
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish processes under which: (1) an entity seeking to develop patient experience data may submit initial research concepts for feedback; (2) the FDA may request or receive from such an entity draft guidance documents, data, and summaries and analyses of data; and (3) patient experience data may be considered in the risk-benefit assessment of a new drug. 
 
&ldquo;Patient experience data&rdquo; is data collected by patients or others that is intended to facilitate the FDA's risk-benefit assessments, including information about the impact of a disease or a therapy on patients' lives.
 The FDA must convene workshops and publish guidance on the patient experience data processes described above.

Legislative actions:
action_date: 2015-05-15
text: Referred to the Subcommittee on Health.
action_date: 2015-05-14
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
To amend title XIX of the Social Security Act to clarify the treatment of lottery winnings and other lump sum income for purposes of income eligibility under the Medicaid program, and for other purposes.

Bill: 114-hr-2339
Sponsor: Rep. Pitts, Joseph R. [R-PA-16]
Introduced: 2015-05-14 in the House
Policy area: Health
Subjects: Gambling
Medicaid

Summary:
action_date: 2015-05-14
text: 
This bill amends title XIX (Medicaid) of the Social Security Act with respect to the treatment of certain lottery winnings and income received as a lump sum in determining income eligibility.
 
A state, in determining the modified adjusted gross income eligibility of a recipient of qualified lottery winnings or qualified lump sum income, may consider such winnings or income as received on a monthly basis if the winnings or income is received in: (1) an amount less than $50,000 over a period of 12 months, or (2) an amount equal to or greater than $50,000 in proportional increments over a state-specified period of up to 240 months.


Legislative actions:
action_date: 2015-05-15
text: Referred to the Subcommittee on Health.
action_date: 2015-05-14
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
To amend the Controlled Substances Import and Export Act to remove regulatory barriers to the re-exportation of controlled substances among members of the European Economic Area.

Bill: 114-hr-2340
Sponsor: Rep. Pitts, Joseph R. [R-PA-16]
Introduced: 2015-05-14 in the House
Policy area: Crime and Law Enforcement
Subjects: Administrative law and regulatory procedures
Department of Justice
Drug trafficking and controlled substances
Europe
European Union
Trade restrictions

Summary:
action_date: 2015-05-14
text: 
 Amends the Controlled Substances Import and Export Act to allow exported controlled substances to be re-exported within the European Economic Area. 
 
Prohibits the Attorney General from promulgating or enforcing any regulation, subregulatory guidance, or enforcement policy that impedes such re-exportation among European Economic Area countries.


Legislative actions:
action_date: 2015-06-26
text: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
action_date: 2015-05-15
text: Referred to the Subcommittee on Health.
action_date: 2015-05-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-05-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-05-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
No Adding, No Padding Act

Bill: 114-hr-2341
Sponsor: Rep. Schrader, Kurt [D-OR-5]
Introduced: 2015-05-14 in the House
Policy area: Economics and Public Finance
Subjects: Appropriations
Budget process
Congressional oversight
Executive agency funding and structure
Government employee pay, benefits, personnel management
Inflation and prices

Summary:
action_date: 2015-05-14
text: 

No Adding, No Padding Act 

 
This bill requires the President's annual budget to include additional details regarding current spending levels and proposed increases. 
 
The budget must include: (1) a list of programs and funding levels that will be a one-time expense for the year for which the budget is submitted, and (2) a proposal for reducing spending in each of the four years following the year for which the budget is submitted. 
 
For each item in the budget that is being conducted in the current year, the budget must include: the funding provided in the current year, any proposed change in the funding, and the justification for the change. If the budget proposes an increase in funding for an item, it must also include the amount of the adjustment that is due to inflation and increases in employee salaries or benefits.
 
The budget must also include estimates for funding that would be included in the budget for the following year if programs and activities received the same amount of funding as provided in the current year. 


Legislative actions:
action_date: 2015-05-14
text: Referred to the House Committee on the Budget.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
Physical Therapist Workforce and Patient Access Act of 2015

Bill: 114-hr-2342
Sponsor: Rep. Shimkus, John [R-IL-15]
Introduced: 2015-05-14 in the House
Policy area: Health
Subjects: Education programs funding
Health personnel
Health programs administration and funding
Long-term, rehabilitative, and terminal care
Medical education
Student aid and college costs

Summary:
action_date: 2015-05-14
text: 

Physical Therapist Workforce and Patient Access Act of 2015

 
Amends the Public Health Service Act to include physical therapy within the definition of &quot;primary health services&quot; for purposes of the National Health Service Corps. Makes physical therapists eligible for repayment of their educational loans in order to ensure an adequate supply of physical therapists.


Legislative actions:
action_date: 2015-05-15
text: Referred to the Subcommittee on Health.
action_date: 2015-05-14
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
To amend the Transportation Equity Act for the 21st Century to modify a high priority project in the State of California, and for other purposes.

Bill: 114-hr-2343
Sponsor: Rep. Waters, Maxine [D-CA-43]
Introduced: 2015-05-14 in the House
Policy area: Transportation and Public Works
Subjects: California
Roads and highways
Transportation programs funding

Summary:
action_date: 2015-05-14
text: 
Amends the Transportation Equity Act for the 21st Century to modify the description of a high priority project funded under such Act in California by replacing &quot;constructing Arbor Vitae street improvements, Inglewood&quot; with &quot;constructing Imperial Highway street improvements designated by the city of Inglewood.&quot;


Legislative actions:
action_date: 2015-05-15
text: Referred to the Subcommittee on Highways and Transit.
action_date: 2015-05-14
text: Referred to the House Committee on Transportation and Infrastructure.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
Veterans Vocational Rehabilitation and Employment Improvement Act of 2015

Bill: 114-hr-2344
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
Introduced: 2015-05-14 in the House
Policy area: Armed Forces and National Security
Subjects: Computers and information technology
Department of Veterans Affairs
Disability and paralysis
Housing for the elderly and disabled
Residential rehabilitation and home repair
Veterans' education, employment, rehabilitation

Summary:
action_date: 2015-05-14
text: 

Veterans Vocational Rehabilitation and Employment Improvement Act of 2015

 
Allows a veteran to pursue a course of education and training as part of a rehabilitation program only if the course is approved under Department of Veterans Affairs (VA) vocational rehabilitation requirements.
 
Makes veterans enrolled in a VA vocational rehabilitation program eligible for VA specially adapted housing.
 
 Bars dual eligibility for home adaptation services.
 
Authorizes the VA to prioritize vocational rehabilitation services based on need and upon consideration of disability ratings, the severity of employment handicaps, qualification for a program of independent living, income, and other appropriate factors. 
 
 Directs the VA to reduce information technology redundancy and inefficiencies in the rehabilitation claims process. 


Legislative actions:
action_date: 2015-06-25
text: Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote .
action_date: 2015-06-25
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2015-06-02
text: Subcommittee Hearings Held.
action_date: 2015-06-01
text: Referred to the Subcommittee on Economic Opportunity.
action_date: 2015-05-14
text: Referred to the House Committee on Veterans' Affairs.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
To extend the date after which interest earned on obligations held in the wildlife restoration fund may be available for apportionment.

Bill: 114-hr-2345
Sponsor: Rep. Wittman, Robert J. [R-VA-1]
Introduced: 2015-05-14 in the House
Policy area: Animals
Subjects: Government trust funds
Interest, dividends, interest rates
Wetlands
Wildlife conservation and habitat protection

Summary:
action_date: 2015-05-14
text: 
This bill amends the Pittman-Robertson Wildlife Restoration Act to delay by 10 years until 2026 the date after which interest from the wildlife conservation and restoration fund is available for apportionment.


Legislative actions:
action_date: 2015-06-04
text: Referred to the Subcommittee on Federal Lands.
action_date: 2015-05-14
text: Referred to the House Committee on Natural Resources.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House
North American Wetlands Conservation Extension Act

Bill: 114-hr-2346
Sponsor: Rep. Wittman, Robert J. [R-VA-1]
Introduced: 2015-05-14 in the House
Policy area: Water Resources Development
Subjects: Water resources funding
Wetlands
Wildlife conservation and habitat protection

Summary:
action_date: 2015-05-14
text: 

North American Wetlands Conservation Extension Act 

 
This bill amends the North American Wetlands Conservation Act to extend the authorization for the Department of the Interior to carry out certain wetlands conservation projects through FY2020. 


Legislative actions:
action_date: 2015-06-04
text: Referred to the Subcommittee on Federal Lands.
action_date: 2015-05-14
text: Referred to the House Committee on Natural Resources.
action_date: 2015-05-14
text: Introduced in House
action_date: 2015-05-14
text: Introduced in House